MedPath

Comparison of left ventricular ejection fraction obtained by using 3D echo modality called 3D EPSS with currently practiced methods of echo 2D EPSS, and 2D simpsons and 3D volumetric methods.

Not Applicable
Conditions
Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Registration Number
CTRI/2023/07/055283
Lead Sponsor
Sree Chitra Tirunal Institute for Medical Sciences and Technology Trivandrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All adults above 18 years of age, in sinus rhythm, admitted with CAD for elective CABG surgery will be included in the study.

Exclusion Criteria

1. Emergency surgeries

2. Redo surgeries

3. Patients not willing to participate in study

4. More than mild AR, MR or TR

5. Patients with Mitral valve pathology causing restricted or increased mobility of leaflets

6. Patients receiving preoperative inotropes

7. Patients with poor echo differentiation of endocardial borders

8. Patient with arrhythmias.

9. Contraindication to TEE probe placement like esophageal strictures, esophageal varices, esophageal

tumors, gastric ulcer, previous esophagectomy, esophageal diverticulum, tracheoesophageal fistula, previous bariatric surgery, hiatus hernia, large descending thoracic aortic aneurysm, unilateral vocal cord paralysis, esophageal varices, post-radiation therapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Comparison of 2D mitral EPSS-based LVEF & 3D mitral EPSS-based LVEF with 2D LVEF measured <br/ ><br>from modified Simpsonâ??s formula in patients with normal LV systolic function (LVEF more than 52% in <br/ ><br>men & 54% in women) & their correlation with LVEF obtained by 3DE volumetric assessment as a reference method. <br/ ><br>2. Correlation of 3D mitral EPSS area with 2DE modified Simpsonâ??s LVEF & 3DE LVEF in patients with <br/ ><br>good LV & deranged LV function. We also would try to derive a formula to calculate LVEF using 3D <br/ ><br>EPSS area. <br/ ><br>Timepoint: Pre CPB initiation <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1. Comparison of LVEF obtained by 2D & 3D mitral EPSS, modified Simpsonâ??s formula and their <br/ ><br>correlation with LVEF obtained by 3DE volumetric assessment as a reference method. <br/ ><br>i.) in patients with deranged LV systolic function <br/ ><br>ii.) in patients without dilated LV <br/ ><br>iii.) formula in patients with dilated LV <br/ ><br> <br/ ><br>2. Correlation of 3D mitral EPSS area with measured LVEF in patients with dilated LV and non-dilated <br/ ><br>LV. We also would try to derive a formula to calculate LVEF using 3D EPSS area. <br/ ><br>3. To assess the correlation between 3D EPSS on postoperative outcome parameters <br/ ><br>4. To ascertain the intraobserver variability and interobserver variability.Timepoint: Pre CPB initiation <br/ ><br>Post extubation <br/ ><br>Pre discharge from IC
© Copyright 2025. All Rights Reserved by MedPath